Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
117.12
+3.79 (3.34%)
At close: Aug 13, 2025, 4:00 PM
116.00
-1.12 (-0.96%)
After-hours: Aug 13, 2025, 7:01 PM EDT
Jazz Pharmaceuticals (JAZZ) Neroscience Revenue Breakdown
History
| Date | Xywav | Epidiolex | Xyrem | Sunosi | Sativex |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1.55B | 996.07M | 179.99M | 63.03M | 19.78M |
| Mar 31, 2025 | 1.50B | 991.44M | 206.83M | 62.19M | 21.55M |
| Dec 31, 2024 | 1.47B | 972.42M | 233.82M | 57.91M | 18.88M |
| Sep 30, 2024 | 1.41B | 938.00M | 291.25M | 51.70M | 18.84M |
| Jun 30, 2024 | 1.35B | 900.15M | 358.24M | 41.56M | 18.88M |
| Mar 31, 2024 | 1.31B | 855.28M | 455.83M | 38.02M | 15.31M |
| Dec 31, 2023 | 1.27B | 845.47M | 569.73M | 28.33M | 19.67M |
| Sep 30, 2023 | 1.22B | 811.84M | 710.51M | - | 19.25M |
| Jun 30, 2023 | 1.14B | 794.35M | 841.43M | - | 17.85M |
| Mar 31, 2023 | 1.05B | 767.41M | 951.09M | - | 19.18M |
| Dec 31, 2022 | 958.43M | 736.40M | 1.02B | - | 16.83M |
| Sep 30, 2022 | 859.70M | 723.19M | 1.06B | - | 16.75M |
| Jun 30, 2022 | 756.82M | 687.35M | 1.11B | - | 19.63M |
| Mar 31, 2022 | 645.96M | 621.54M | 1.18B | - | 17.45M |
| Dec 31, 2021 | 535.30M | - | 1.27B | - | - |
| Sep 30, 2021 | 367.91M | - | 1.42B | - | - |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.